Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at the expense of vulnerable patients.
The Federal Trade Commission (FTC) filed a lawsuit Friday against three major prescription drug benefit managers (PBMs) and ...
A Federal Trade Commission (FTC) report found that social and video streaming services pose serious privacy risks, especially ...
A decision on the Federal Trade Commission’s noncompete ban came down to the wire. A federal judge in Texas recently blocked the FTC’s noncompete ban, which was approved by the commission ...
In her ruling, Brown found the FTC lacks statutory authority to issue substantive rules, which are rules issued by administrative agencies that have the force of laws, regarding unfair competition.
At this week’s National Advertising Division Annual Conference, FTC Commissioner Melissa Holyoak and FTC Bureau of Consumer Protection Director ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback